A Brief Overview of Psychedelic Policy
Psychedelic policy in the United States is rapidly changing, moving from strict prohibition to more nuanced approaches like decriminalization and regulated therapeutic use.
This blog breaks down these shifts, exploring the legal landscape from harsh penalties to groundbreaking initiatives that support harm reduction, medical research, and Indigenous rights.
This overview will help you understand the key developments shaping the future of psychedelics in America.
Prohibition and Criminalization:
Historically, most psychedelics in the United States have been classified as illegal substances under international treaties such as the 1971 United Nations Convention on Psychotropic Substances.
In the United States, psychedelics are illegal and categorized as Schedule I substances according to the DEA, indicating they are considered to have a high potential for abuse and no accepted medical use.
Harsh penalties for possession, use, and distribution of psychedelics are common, often resulting in significant legal consequences, including incarceration.
The stigmatization of psychedelics has hindered scientific research potentially due to their illegal status and public misconceptions of their use.
Decriminalization:
Decriminalization of drugs refers to the reduction of criminal penalties for drug possession and use, typically replacing them with civil penalties.
Police can still enforce certain laws, and individuals can still face legal consequences. Decriminalization focuses on making specific substances the “lowest priority” for local law enforcement.
Municipal Initiatives: Several cities in the United States, such as Denver, Oakland, and Seattle, have decriminalized the possession and use of certain psychedelics, particularly psilocybin mushrooms. The public is advised to check with local law enforcement.
State-Level Efforts: Oregon made history in 2020 by passing Measure 109, which allows for the regulated medical use of psilocybin, and Measure 110, decriminalizing possession of small amounts of all drugs.
Medical and Therapeutic Use:
Clinical Trials and Research: Psychedelic substances like psilocybin, MDMA, and LSD are currently being studied legally for their potential to treat various mental health conditions, including depression, PTSD, and anxiety.
Compassionate Use Programs: Some countries, like Canada, have granted exemptions for the therapeutic use of psychedelics on a case-by-case basis.
Regulated Therapy Models: The states of Oregon and Colorado, as well as other jurisdictions, are developing frameworks to allow for the regulated use of psychedelics in therapeutic settings.
Legalization:
Broad Legalization: Broad legalization of psychedelics is not widespread. Some countries, like Brazil, Peru, Costa Rica, and Jamaica, have more permissive laws regarding certain substances.
Controlled Legalization: Countries like the Netherlands allow the sale and use of certain psychedelics, such as psilocybin truffles, under regulated conditions.
Legalization in the US will look different state by state.
Religious and Indigenous Use:
H.R.4230 - American Indian Religious Freedom Act Amendments of 1994 - Amends the American Indian Religious Freedom Act to permit the traditional use of peyote for Indian religious purposes.
Indigenous advocates have requested that peyote be left off decriminalization bills to protect it for their religious use.
The Church of the Eagle and the Condor (CEC) was granted protection for using ayahuasca in its spiritual practices in 2024.
The settlement was an agreement with the Drug Enforcement Administration (DEA), the Department of Homeland Security (DHS), Customs and Border Protection (CBP), and the Department of Justice (DOJ). This is the first time a non-Christian church has been granted protection for using ayahuasca.
Harm Reduction and Education:
Harm Reduction Programs: Organizations and governments in some areas are implementing harm reduction strategies, such as drug-checking services and education campaigns, to minimize the risks associated with psychedelic use.
Public Education: Increasing awareness and understanding of the potential benefits and risks of psychedelics through public education initiatives is becoming more common.
Future Trends:
Evolving Legislation: As scientific research continues to highlight the potential therapeutic benefits of psychedelics, there is a growing movement toward more nuanced and supportive legislation.
Global Shifts: Countries around the world are beginning to reassess their policies on psychedelics, potentially leading to broader acceptance and integration of these substances into medical and therapeutic frameworks. Ayahuasca is legal in Peru, Colombia, Italy, Brazil, Ecuador, & Bolivia for example.
The landscape of psychedelic policy is dynamic and complex, with a mixture of prohibition, indigenous rights, decriminalization, regulated medical use, coaching, and harm reduction.
Not everyone agrees on evolving legal and social initiatives, and we hope this article supports your learning process.
If you are curious about regional events, please view our Regional Event Calendar.
Our Podcast is dedicated to providing in-depth analysis, expert perspectives, and a holistic view of how psychedelics influence health, the economy, and society.
